Latest News of GFR
RYBREVANT® plus chemotherapy approved in Canada as first and only targeted treatment to reduce risk of disease progression or death by more than half in second-line EGFR-mutated advanced lung cancer
By Yahoo! Finance | 1 month ago
At UK£3.92, Is It Time To Put Galliford Try Holdings plc (LON:GFRD) On Your Watch List?
By Yahoo! Finance | 1 month ago
Siegfried Holding AG (VTX:SFZN) Shares Could Be 24% Above Their Intrinsic Value Estimate
By Yahoo! Finance | 1 month ago